logo
Select company
Select metric
0%Inventory to Assets Ratio
VS
Market
48
Sector
44
Industry
23
History
-
$ 2.36Close
$ 2 - $ 2.7 52-Week Range
Ticker Information

Ticker

ORMP

Company Name

ORAMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ORAMED PHARMACEUTICALS INC - Inventory to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ORMP - Inv. to Assets Historical data
DateTotal AssetsInventoryInventory to Assets Ratio
6/30/2025$ 161.68M$ 00%
3/31/2025$ 147.54M$ 00%
12/31/2024$ 155.28M$ 00%
9/30/2024$ 165.08M$ 00%
6/30/2024$ 184.22M$ 00%
3/31/2024$ 203.65M$ 00%
12/31/2023$ 220.55M$ 00%
9/30/2023$ 230.89M$ 00%
6/30/2023$ 156.31M$ 00%
3/31/2023$ 159.78M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) Inv. to Assets stands at 0%.
  • Over the past 5 years, ORAMED PHARMACEUTICALS INC's average Inv. to Assets has been 0%.
  • The median Inv. to Assets for ORAMED PHARMACEUTICALS INC during this period was 0%
  • ORAMED PHARMACEUTICALS INC reached its highest Inv. to Assets over the past 5 years at 0%.
  • The lowest Inv. to Assets recorded by ORAMED PHARMACEUTICALS INC in the same timeframe 0%

ORAMED PHARMACEUTICALS INC's Inv. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. to Assets Benchmarks
CompanyInv. to Assets
NTRB : NUTRIBAND INC 1.36%OTLK : OUTLOOK THERAPEUTICS INC 18.43%CNTB : CONNECT BIOPHARMA HOLDINGS LTD 0%PYXS : PYXIS ONCOLOGY INC 0%BTAI : BIOXCEL THERAPEUTICS INC 1.96%VTGN : VISTAGEN THERAPEUTICS INC 0%DTIL : PRECISION BIOSCIENCES INC 0%LGVN : LONGEVERON INC 0%PLUR : PLURI INC 0%ADVM : ADVERUM BIOTECHNOLOGIES INC 0%

Definition of Inventory to Assets Ratio

[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for ORAMED PHARMACEUTICALS INC is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 44.63M ]
(=) Inv. to Assets [ 0% ]

ORMP - Inventory to Assets Ratio, Last 5 years

0%

Minimum

Sep 30, 2020

0%

Maximum

Sep 30, 2020

0%

Average

0%

Median

Inv. to Assets Benchmark Analysis

The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.08% with a standard deviation of 11.1%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
filtered constituents4.46K
min0%
max98.39%
average6.08%
median0%
std11.1%